SCHEMBL352265

SCHEMBL352265

CN(Cc1nsc(NC(=O)NCc2ccc(Cl)s2)n1)C(=O)C1Cc2ccccc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TSHR P16473 1/20 0.41
GLS O94925 3/20 0.38
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
CYP2D6 P10635 2/20 0.32
OPRK1 P41145 2/20 0.32
SENP7 Q9BQF6 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352928 0.87 SIRT1 (0.38) ALDH1A1GLSNFKB1NFKB2RELA
SCHEMBL19119546 0.87 ALDH1A1 (0.36) ALDH1A1TSHRGLSGRM1KMT2A
SCHEMBL352939 0.83 ROCK2 (0.42) ALDH1A1TSHRGLSKMT2ATP53
SCHEMBL354802 0.82 SMN1; SMN2 (0.37) ALDH1A1TSHRNFKB1NFKB2RELA
SCHEMBL19118740 0.78 ALDH1A1 (0.33) ALDH1A1TSHRKMT2ARAB9AHTT
SCHEMBL353615 0.77 ALDH1A1 (0.32) ALDH1A1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL352906 0.77 ALOX15 (0.36) ALDH1A1HDAC1HDAC8HDAC6KMT2A
SCHEMBL352911 0.76 HSD11B1 (0.42) ALDH1A1TSHRCYP2D6KMT2ARAB9A
SCHEMBL353960 0.76 HTT (0.36) ALDH1A1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL19119454 0.76 ALDH1A1 (0.33) ALDH1A1KMT2ARAB9AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US claimed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA ALDH1A1 2806/4885TSHR 2748/4885GLS 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.